Trial Profile
Tolcapone Treatment of Pathological Gambling: An Open-Label Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Nov 2019
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Gambling
- Focus Therapeutic Use
- 30 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov record.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Mar 2012 Planned End Date changed from 1 Nov 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.